JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
D. Thomson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, D.
Right arrow Articles by Mayers, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, D.
Right arrow Articles by Mayers, I.

J Thorac Cardiovasc Surg 1994;107:1193-1202
© 1994 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

Neutrophil-mediated acute lung injury after extracorporeal perfusion

D. Johnson, MD, FRCP(C)ab, D. Thomson, MD, FRCS(C)c, T. Hurst, BVetSc, MVetScb, K. Prasad, MD, PhDd, T. Wilson, MD, FRCP(C)be, F. Murphy, MD, FRCP(C)f, A. Saxena, MDf, I. Mayers, MD, FRCP(C)b


Saskatoon, Saskatchewan, Canada

Supported by a grant from the Canadian Heart and Stroke Foundation.

Received for publication May 19, 1993. Accepted for publication Nov. 8, 1993. Address for reprints: David Johnson, MD, Box 95, Royal University Hospital, Saskatoon, Saskatchewan, Canada S7N 4J9.

Abstract

A pulmonary injury of varying severity occurs routinely after cardiopulmonary bypass. We studied the pulmonary complications of partial cardiopulmonary bypass in four groups of dogs to better define the injury and to evaluate the efficacy of two interventions (addition of a leukocyte filter or cyclooxygenase inhibition) on preservation of systemic oxygenation. All animals received a standard anesthetic (pentobarbital, morphine, and vecuronium) and, after sternotomy, three groups of animals received 3 hours of partial cardiopulmonary bypass. The animals were randomized to receive partial bypass alone (n = 6), indomethacin and bypass (n = 5), or a leukocyte filter and bypass (n = 5). A fourth group (n = 5) did not receive bypass and served as a time control. We measured blood gases and also obtained histologic samples to assess the degree of lung injury. We found that bypass alone caused a significant reduction (p < 0.05) in arterial oxygen tension 1 hour after the conclusion of bypass (175 ± 53 mm Hg) compared with prebypass values (357 ± 41 mm Hg). Pretreatment with indomethacin ameliorated the decrease in arterial oxygen tension from prebypass to postbypass values (477 ± 50 mm Hg versus 339 ± 57 mm Hg, respectively). Similarly use of a leukocyte filter reduced the decline in arterial oxygen tension from prebypass to postbypass values (440 ± 71 mm Hg versus 311 ± 73 mm Hg, respectively). We believe that indomethacin ameliorates the decline in systemic oxygenation associated with bypass by augmentation of hypoxic pulmonary vasoconstriction and that the leukocyte filter acted to reduce pulmonary edema and thereby minimized intrapulmonary shunt. (J THORACCARDIOVASCSURG1994;107:1193-1202)




This article has been cited by other articles:


Home page
ICVTSHome page
L. C.H. John and I. M. Ervine
A study assessing the potential benefit of continued ventilation during cardiopulmonary bypass
Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 14 - 17.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. A Hassantash, G. R Omrani, N. Givtaj, and M. Afrakhteh
Pharmacological Prevention of the Deleterious Effects of Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Jiang, Q. Wang, Y. Liu, M. Du, X. Shen, X. Guo, and S. Wu
Total liquid ventilation reduces lung injury in piglets after cardiopulmonary bypass.
Ann. Thorac. Surg., July 1, 2006; 82(1): 124 - 130.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S. C Clark
Lung Injury after Cardiopulmonary Bypass
Perfusion, July 1, 2006; 21(4): 225 - 228.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
X. Fan, Y. Liu, Q. Wang, C. Yu, B. Wei, and Y. Ruan
Lung Perfusion With Clarithromycin Ameliorates Lung Function After Cardiopulmonary Bypass.
Ann. Thorac. Surg., March 1, 2006; 81(3): 896 - 901.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Sato, Y. Hiramatsu, S. Homma, M. Sato, S. Sato, S. Endo, and Y. Sohara
Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 346 - 350.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Gerrah, A. Elami, A. Stamler, A. Smirnov, and Z. Stoeger
Preoperative Aspirin Administration Improves Oxygenation in Patients Undergoing Coronary Artery Bypass Grafting
Chest, May 1, 2005; 127(5): 1622 - 1626.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A J de Vries, Y J Gu, and W van Oeveren
Leucocyte filtration of residual heart-lung machine blood in children undergoing congenital heart surgery
Perfusion, December 1, 2004; 19(6): 345 - 349.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. Karaiskos, G. M. Palatianos, C. D. Triantafillou, G. H. Kantidakis, G. M. Astras, E. G. Papadakis, and M. I. Vassili
Clinical Effectiveness of Leukocyte Filtration During Cardiopulmonary Bypass in Patients with Chronic Obstructive Pulmonary Disease
Ann. Thorac. Surg., October 1, 2004; 78(4): 1339 - 1344.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
N. Eren, O. Cakir, A. Oruc, Z. Kaya, and L. Erdinc
Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass
Perfusion, December 1, 2003; 18(6): 345 - 350.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Cakir, A. Oruc, S. Eren, H. Buyukbayram, L. Erdinc, and N. Eren
Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass?
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1040 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Yoshimura, Y. Hiramatsu, Y. Sato, S. Homma, Y. Enomoto, Y. Kikuchi, and Y. Sakakibara
Activated neutrophils and platelet microaggregates impede blood filterability through microchannels during simulated extracorporeal circulation
Ann. Thorac. Surg., April 1, 2003; 75(4): 1254 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Sato, Y. Hiramatsu, S. Homma, S. Sato, M. Onizuka, and Y. Sakakibara
Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model
J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 172 - 177.
[Abstract] [Full Text]


Home page
PerfusionHome page
A H Olivencia-Yurvati, C A Ferrara, N Tierney, N Wallace, and R T Mallet
Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass
Perfusion, January 1, 2003; 18(1_suppl): 23 - 31.
[Abstract] [PDF]


Home page
PerfusionHome page
W. G. Kim, B.-H. Lee, and J. W. Seo
Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model
Perfusion, May 1, 2001; 16(3): 207 - 214.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. P. Taggart
Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation
Ann. Thorac. Surg., January 1, 2001; 71(1): 238 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Hayashi, Y. Sawa, M. Nishimura, S. J. Tojo, N. Fukuyama, H. Nakazawa, and H. Matsuda
P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrite production
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 558 - 565.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Belboul, C. Lofgren, C. Storm, and M. Jungbeck
Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial
Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 580 - 586.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Carney, C. J. Lutz, A. L. Picone, L. A. Gatto, N. S. Ramamurthy, L. M. Golub, S. R. Simon, B. Searles, A. Paskanik, K. Snyder, et al.
Matrix Metalloproteinase Inhibitor Prevents Acute Lung Injury After Cardiopulmonary Bypass
Circulation, July 27, 1999; 100(4): 400 - 406.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
G. Asimakopoulos
Mechanisms of the systemic inflammatory response
Perfusion, July 1, 1999; 14(4): 269 - 277.
[PDF]


Home page
PerfusionHome page
S T Baksaas, V Videm, T E Mollnes, S Tollofsrud, G Hetland, T Pedersen, and J L Svennevig
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
Perfusion, December 1, 1998; 13(6): 429 - 436.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Gohra, Y. Fujimura, H. Ito, K. Hamano, T. Katoh, N. Zempo, and K. Esato
Granulocyte Elastase Release and Pulmonary Hemodynamics in Patients With Atrial Septal Defect
Ann. Thorac. Surg., March 1, 1998; 65(3): 719 - 723.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A J Heggie, J S Corder, P R Crichton, J W Hesford, H Bingham, S Jeffries, and T L Hooper
Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1)
Perfusion, January 1, 1998; 13(1): 17 - 25.
[Abstract] [PDF]


Home page
PerfusionHome page
M Ranucci, G Soro, A Frigiola, L Menicanti, A Ditta, G Candido, and S Tambalo
Normothermic perfusion and lung function after cardiopulmonary bypass: effects in pulmonary risk patients
Perfusion, September 1, 1997; 12(5): 309 - 315.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. A. Skaryak, A. J. Lodge, P. M. Kirshbom, L. R. DiBernardo, B. G. Wilson, J. N. Meliones, R. M. Ungerleider, and J. W. Gaynor
Low-Flow Cardiopulmonary Bypass Produces Greater Pulmonary Dysfunction Than Circulatory Arrest
Ann. Thorac. Surg., November 1, 1996; 62(5): 1284 - 1288.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. L. Korn, C. A. Fisher, E. R. Livingston, N. Stenach, S. J. Fishman, V. Jeevanandam, and V. P. Addonizio
THE EFFECTS OF CARMEDA BIOACTIVE SURFACE ON HUMAN BLOOD COMPONENTS DURING SIMULATED EXTRACORPOREAL CIRCULATION
J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 1073 - 1084.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Friedman, S. Y. Wang, F. W. Sellke, W. E. Cohn, R. M. Weintraub, and R. G. Johnson
NEUTROPHIL ADHESION BLOCKADE WITH NPC 15669 DECREASES PULMONARY INJURY AFTER TOTAL CARDIOPULMONARY BYPASS
J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 460 - 468.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Ranucci, S. Cirri, D. Conti, A. Ditta, A. Boncilli, A. Frigiola, and L. Menicanti
Beneficial Effects of Duraflo II Heparin-Coated Circuits on Postperfusion Lung Dysfunction
Ann. Thorac. Surg., January 1, 1996; 61(1): 76 - 81.
[Abstract] [Full Text]


Home page
PerfusionHome page
D. F Larson, M. Bowers, and H W. Schechner
Neutrophil activation during cardiopulmonary bypass in paediatric and adult patients
Perfusion, January 1, 1996; 11(1): 21 - 27.
[Abstract] [PDF]


Home page
PerfusionHome page
G. A Ortolano
Potential for reduction in morbidity and cost with total leucocyte control for cardiac surgery
Perfusion, September 1, 1995; 10(5): 283 - 290.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The American Association for Thoracic Surgery.